Provectus Biopharma provides annual meeting update, slides attached

PROVECTUS BIOPHARMACEUTICALS, INC.

Update covers clinical development, regulatory, drug discovery, manufacturing, IP, business and corporate development.
Presentation slides filed as Exhibit 99.1 but not reproduced; specific details not available in this filing summary.
No financial results, guidance, or milestones disclosed in the 8-K body; rely on the attached slides for materiality.
Filing under Regulation FD; information is furnished, not filed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.